Pharmaceutical aspects of the recombinant human serum albumin dimer

Structural characteristics, biological properties, and medical applications

Kazuaki Taguchi, Victor Tuan Giam Chuang, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Human serum albumin is the most abundant protein in the blood. It is clinically used in the treatment of severe hypoalbuminemia and as a plasma expander. The use of albumins as a carrier for drugs is currently being developed, and some are now in the preclinical and clinical trial stages. The main technologies for utilizing an albumin as a drug carrier are protein fusion, polymerization and surface modification, and so on. Among these technologies, albumin dimerization has wide clinical applications as a plasma expander as well as a drug carrier. Despite the fact that many reports have appeared on drugs using an albumin dimer as a carrier, our knowledge of the characteristics of the albumin dimer itself is incomplete. In this review, we summarize the structural characteristics of recombinant albumin dimers produced by two methods, namely, chemical linkage with 1,6-bis(maleimido)hexane and genetically linked with an amino acid linker, and the physicochemical characteristics and biological properties of these preparations. Finally, the potential for pharmaceutical applications of albumin dimers in clinical situations is discussed.

Original languageEnglish
Pages (from-to)3033-3046
Number of pages14
JournalJournal of Pharmaceutical Sciences
Volume101
Issue number9
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Fingerprint

Serum Albumin
Albumins
Drug Carriers
Pharmaceutical Preparations
Technology
Hypoalbuminemia
Dimerization
Hexanes
Polymerization
Blood Proteins
Carrier Proteins
Clinical Trials
Amino Acids

Keywords

  • Albumin
  • Biomaterials
  • Disposition
  • Drug delivery systems
  • Nanotechnology
  • Physicochemical properties
  • Polymeric biomaterials

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Pharmaceutical aspects of the recombinant human serum albumin dimer : Structural characteristics, biological properties, and medical applications. / Taguchi, Kazuaki; Giam Chuang, Victor Tuan; Maruyama, Toru; Otagiri, Masaki.

In: Journal of Pharmaceutical Sciences, Vol. 101, No. 9, 01.01.2012, p. 3033-3046.

Research output: Contribution to journalReview article

Taguchi, Kazuaki ; Giam Chuang, Victor Tuan ; Maruyama, Toru ; Otagiri, Masaki. / Pharmaceutical aspects of the recombinant human serum albumin dimer : Structural characteristics, biological properties, and medical applications. In: Journal of Pharmaceutical Sciences. 2012 ; Vol. 101, No. 9. pp. 3033-3046.
@article{8a31d79579e044d28028b5bd4a8792de,
title = "Pharmaceutical aspects of the recombinant human serum albumin dimer: Structural characteristics, biological properties, and medical applications",
abstract = "Human serum albumin is the most abundant protein in the blood. It is clinically used in the treatment of severe hypoalbuminemia and as a plasma expander. The use of albumins as a carrier for drugs is currently being developed, and some are now in the preclinical and clinical trial stages. The main technologies for utilizing an albumin as a drug carrier are protein fusion, polymerization and surface modification, and so on. Among these technologies, albumin dimerization has wide clinical applications as a plasma expander as well as a drug carrier. Despite the fact that many reports have appeared on drugs using an albumin dimer as a carrier, our knowledge of the characteristics of the albumin dimer itself is incomplete. In this review, we summarize the structural characteristics of recombinant albumin dimers produced by two methods, namely, chemical linkage with 1,6-bis(maleimido)hexane and genetically linked with an amino acid linker, and the physicochemical characteristics and biological properties of these preparations. Finally, the potential for pharmaceutical applications of albumin dimers in clinical situations is discussed.",
keywords = "Albumin, Biomaterials, Disposition, Drug delivery systems, Nanotechnology, Physicochemical properties, Polymeric biomaterials",
author = "Kazuaki Taguchi and {Giam Chuang}, {Victor Tuan} and Toru Maruyama and Masaki Otagiri",
year = "2012",
month = "1",
day = "1",
doi = "10.1002/jps.23181",
language = "English",
volume = "101",
pages = "3033--3046",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Pharmaceutical aspects of the recombinant human serum albumin dimer

T2 - Structural characteristics, biological properties, and medical applications

AU - Taguchi, Kazuaki

AU - Giam Chuang, Victor Tuan

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Human serum albumin is the most abundant protein in the blood. It is clinically used in the treatment of severe hypoalbuminemia and as a plasma expander. The use of albumins as a carrier for drugs is currently being developed, and some are now in the preclinical and clinical trial stages. The main technologies for utilizing an albumin as a drug carrier are protein fusion, polymerization and surface modification, and so on. Among these technologies, albumin dimerization has wide clinical applications as a plasma expander as well as a drug carrier. Despite the fact that many reports have appeared on drugs using an albumin dimer as a carrier, our knowledge of the characteristics of the albumin dimer itself is incomplete. In this review, we summarize the structural characteristics of recombinant albumin dimers produced by two methods, namely, chemical linkage with 1,6-bis(maleimido)hexane and genetically linked with an amino acid linker, and the physicochemical characteristics and biological properties of these preparations. Finally, the potential for pharmaceutical applications of albumin dimers in clinical situations is discussed.

AB - Human serum albumin is the most abundant protein in the blood. It is clinically used in the treatment of severe hypoalbuminemia and as a plasma expander. The use of albumins as a carrier for drugs is currently being developed, and some are now in the preclinical and clinical trial stages. The main technologies for utilizing an albumin as a drug carrier are protein fusion, polymerization and surface modification, and so on. Among these technologies, albumin dimerization has wide clinical applications as a plasma expander as well as a drug carrier. Despite the fact that many reports have appeared on drugs using an albumin dimer as a carrier, our knowledge of the characteristics of the albumin dimer itself is incomplete. In this review, we summarize the structural characteristics of recombinant albumin dimers produced by two methods, namely, chemical linkage with 1,6-bis(maleimido)hexane and genetically linked with an amino acid linker, and the physicochemical characteristics and biological properties of these preparations. Finally, the potential for pharmaceutical applications of albumin dimers in clinical situations is discussed.

KW - Albumin

KW - Biomaterials

KW - Disposition

KW - Drug delivery systems

KW - Nanotechnology

KW - Physicochemical properties

KW - Polymeric biomaterials

UR - http://www.scopus.com/inward/record.url?scp=84864057941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864057941&partnerID=8YFLogxK

U2 - 10.1002/jps.23181

DO - 10.1002/jps.23181

M3 - Review article

VL - 101

SP - 3033

EP - 3046

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 9

ER -